CombiMatrix Corporation, US
Keywords: combinatorial discovery platform, nanomaterials, microelectrode sensor arrays, biochip
CombiMatrix has developed a core technology which is comprised of a semiconductor chip, that enables the execution of multiple, independent chemical experiments in parallel. This lab-on-a-chip is an interdisciplinary marriage of nanotechnology, biology and microelectronics. This chip consists of an array of 1000 to 18000 microelectrodes on a square centimeter, each of which is independently addressable. In analogy with conventional microprocessors, each microelectrode can be thought of as a transistor, which performs a chemical reaction. Consequently, the density of microelectrodes can be increased to levels up to several million per square centimeter. Experiments that would take months or years can now be performed in days using CombiMatrix chips. CombiMatrix focuses on high growth and emerging markets. The company has publicly stated that there are four markets utilizing its chip technology, namely, nanotechnology, genetic analysis, homeland security, and nucleic acid drug discovery. CombiMatrix is always seeking other applications of its technology and is working with partners to do so. The strategy is to work with partners to fund its internal efforts and to leverage its internal capabilities. CombiMatrix seeks partners with technical capabilities not internally available, to provide funding for development programs and to access commercialization channels.
Nanotech 2004 Conference Technical Program Abstract